These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 38902779)

  • 21. RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy.
    Shi JX; Zhang ZC; Yin HZ; Piao XJ; Liu CH; Liu QJ; Zhang JC; Zhou WX; Liu FC; Yang F; Wang YF; Liu H
    Mol Cancer; 2024 Sep; 23(1):213. PubMed ID: 39342168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N
    Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
    Front Immunol; 2021; 12():697026. PubMed ID: 34526985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles and mechanism of m
    Chen L; He Y; Zhu J; Zhao S; Qi S; Chen X; Zhang H; Ni Z; Zhou Y; Chen G; Liu S; Xie T
    Biomed Pharmacother; 2023 Jul; 163():114839. PubMed ID: 37156113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder.
    Mu S; Zhao K; Zhong S; Wang Y
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research progress of N1-methyladenosine RNA modification in cancer.
    Liu Y; Zhang S; Gao X; Ru Y; Gu X; Hu X
    Cell Commun Signal; 2024 Jan; 22(1):79. PubMed ID: 38291517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N
    Li J; Zhang H; Wang H
    Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression.
    Wei L; Liu S; Xie Z; Tang G; Lei X; Yang X
    Int Immunopharmacol; 2024 Oct; 140():112824. PubMed ID: 39116490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
    Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
    Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
    Shi H; Chai P; Jia R; Fan X
    Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of RNA m
    Zhao Y; Sun H; Zheng J; Shao C
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):407-435. PubMed ID: 33905280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview of Current Detection Methods for RNA Methylation.
    Sağlam B; Akgül B
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolving landscape of N
    Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
    Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.